商务合作
动脉网APP
可切换为仅中文
What You Should Know:
您应该知道:
– Opmed.ai, the AI optimization platform for healthcare, announced today the successful raise of $15M in series A funding.
–医疗保健人工智能优化平台Opmed.ai今天宣布,成功筹集了1500万美元的A系列资金。
– The round was co-led by NFX and Grove Ventures, with Secret Chord Ventures, the Impact investor Sir Ronald Cohen, and Unbox Ventures also participating
–本轮由NFX和Grove Ventures共同领导,秘密和弦投资公司、影响力投资者罗纳德·科恩爵士和Unbox Ventures也参与了
Revolutionizing Healthcare Efficiency: Opmed.ai’s AI-Powered OR Optimization Solutions
彻底改变医疗效率:Opmed.ai的人工智能或优化解决方案
The funding announcement arrives amidst a critical shortage in healthcare labor, with projections indicating a deficit of 3.2 million healthcare professionals by 2026. Meanwhile, hospitals grapple with escalating labor costs, which surged beyond 20% last year. Operating Rooms (ORs) constitute a substantial portion, accounting for 40% of a hospital’s expenses while generating 60-70% of its revenue, often serving as the primary driver of profitability.
这项资金宣布正值医疗保健劳动力严重短缺之际,预计到2026年,医疗保健专业人员将短缺320万人。与此同时,医院正在努力应对不断上涨的劳动力成本,去年劳动力成本飙升超过20%。手术室(OR)占医院费用的40%,同时产生60-70%的收入,通常是盈利能力的主要驱动因素。
Nonetheless, the inefficiencies in OR scheduling, facilitated through archaic spreadsheets or predominantly manual methods, compound these challenges..
尽管如此,通过古老的电子表格或主要是手动方法促进的OR调度效率低下,加剧了这些挑战。。
Enter Opmed.ai, specializing in optimizing healthcare operations, with a primary focus on OR efficiency, leveraging advanced AI technology. The company’s optimization engine rapidly assesses billions of permutations, customized to forecast based on industry-specific variables, automatically generating alternative schedules that vastly enhance resource utilization.
进入Opmed.ai,专注于优化医疗保健运营,主要关注或效率,利用先进的人工智能技术。该公司的优化引擎可以快速评估数十亿个排列,并根据行业特定变量进行定制预测,自动生成替代时间表,从而大大提高资源利用率。
Considering that each idle minute potentially translates to revenue losses ranging from $50 to $150, with empty ORs incurring costs of $1,000 per unused hour, the impact of this technology is profound. By adopting Opmed.ai, hospitals stand to gain over $1 million per OR in additional revenue annually, while concurrently slashing costs by $500,000 and fortifying resilience against unforeseen disruptions..
考虑到每空闲一分钟都可能导致收入损失,从50美元到150美元不等,空的ORs每未使用一小时会产生1000美元的成本,这项技术的影响是深远的。通过采用Opmed.ai,医院每年将获得超过100万美元的额外收入,同时将成本削减50万美元,增强对不可预见的中断的恢复能力。。
Despite the intricate nature of ORs and healthcare environments at large, Opmed.ai boasts an implementation timeframe of merely two to four weeks. Once deployed, it identifies over and underestimations, addresses gaps, anesthesia durations, turnover times, and other pertinent factors, subsequently generating optimized alternative plans.
尽管ORs和医疗保健环境的性质错综复杂,但Opmed.ai的实施时间仅为两到四周。一旦部署,它可以识别过高和过低的估计,解决差距,麻醉持续时间,周转时间和其他相关因素,随后产生优化的替代计划。
These plans account for staffing, equipment, preferences, add-ons, and various other considerations, streamlining the process for scheduling professionals with just a few clicks. Moreover, the platform facilitates the creation of longer-term quarterly and yearly block allocation plans, driving OR utilization up by 10% and yielding compounded savings and revenue.
这些计划考虑了人员配置、设备、偏好、附加组件和其他各种考虑因素,简化了只需单击几下即可安排专业人员的流程。此外,该平台有助于创建长期的季度和年度区块分配计划,推动或利用率提高10%,并产生复合储蓄和收入。
Remarkably, the return on investment for hospitals typically materializes within a mere 3-4 months..
值得注意的是,医院的投资回报通常仅在3-4个月内实现。。
Founded by Dr. Mor Brokman Meltzer, Avi Paz, and Prof. Baruch Barzel, Opmed.ai presents an innovative healthcare optimization engine, harnessing AI and network science to revolutionize healthcare scheduling and resource allocation, commencing with operating rooms.
Opmed.ai由Mor Brokman Meltzer博士、Avi Paz博士和Baruch Barzel教授创立,它提供了一个创新的医疗保健优化引擎,利用人工智能和网络科学彻底改变医疗保健计划和资源分配,从手术室开始。
“Opmed.ai is a perfect representation of the next generation of great AI platforms. They solve a complex issue with a highly specialized vertical solution that has no alternative that comes close,” said Renana Ashkenazi, General Partner of Grove Ventures. “Adding to the attractiveness of the investment is the fact that the ROI is so clear and significant, even from an early stage.
Grove Ventures的普通合伙人Renana Ashkenazi表示:“Opmed.ai是下一代优秀人工智能平台的完美代表。它们通过高度专业化的垂直解决方案解决了一个复杂的问题,没有替代方案。”。“投资回报率如此清晰且显著,即便是在早期阶段,这一事实也增加了投资的吸引力。
We’ve seen the millions of dollars it has saved and generated in hospitals where it’s already deployed, and as impressed as we were, the hospitals’ enthusiasm has been even greater. We look forward to helping the Opmed.ai team rapidly expand in both the hospitals and use cases they serve.”.
我们已经看到它在已经部署的医院节省和产生了数百万美元,尽管我们印象深刻,医院的热情甚至更高。我们期待着帮助Opmed.ai团队在医院和他们所服务的用例中迅速扩展。”。